SAMe, RXRalpha-mediated Pathways and ALD
SAMe, RXRalpha-mediated Pathways and ALD
批准号:
6859130
负责人:
Yu-Jui Yvonne Wan
金额:
$26.94万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2006-07-31
关键词:
S adenosylmethionine acetaldehyde biological signal transduction enzymes ethanol gene expression gene targeting genetically modified animals glutathione laboratory mouse liver cells liver disorder metabolism methionine methyltransferase nuclear receptors phosphatidylcholines retinoid binding proteins retinoids tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to study the mechanism underlying nuclear receptor retinoid x receptor et (RXR-alpha)-mediated pathways on regulating S-adenosyl-L-methionine (SAMe) homeostasis. The main hypothesis is that RXR-alpha-mediated pathways either directly or indirectly control SAMe synthesis and alter the levels of glutathione and phosphatidylcholine in the liver, which consequently play a crucial role in the development of alcoholic liver disease (ALD). Most of the retinol and alcohol studies rely on either feeding animals with excess amount of retinoids or introducing animals with retinol deficient diet. Feeding animals with retinoids can be toxic. Retinol deficiency can also cause many unwanted effects. Knockout technology avoids these potential problems. Tissue specific knockout further allows studying the function of the gene in a cell type specific manner without affecting the gene function systemically. We have established an animal model in that the RXR-alpha gene is knocked out only in the hepatocyte. RXR-alpha is highly expressed in the liver and is required for almost all the nuclear receptor-mediated pathways. Therefore, hepatocyte RXR-alpha deficient mouse serves as an excellent model for studying retinoid signaling in alcoholic liver disease. When hepatocyte RXR-alpha is deficient, liver retinoic acid is elevated, alcohol elimination rate is increased and alcohol-induced liver damage becomes more severe. In addition, the expression of more than ten genes encoding enzymes involved in the SAMe pathway is altered. Those data indicate that RXR-alpha, SAMe and ALD are intricately interlinked. Two specific aims are proposed to study the direct and indirect effect of RXR-alpha on SAMe homeostasis. First is to examine how RXR-alpha-mediated pathways regulate alcohol metabolism, which may indirectly control SAMe synthesis and affect the development of ALD. Second is to characterize how RXR-alpha-mediated pathways regulate genes encoding enzymes in the SAMe pathway and directly control SAMe homeostasis. RXR-alpha-mediated pathways including PPARcz and 3' and RXR-alpha homodimer and others will be studied. The effect of those nuclear receptor ligands on regulating SAMe synthesis will be analyzed. The proposed study not only allows us to understand how nuclear receptors regulate SAMe homeostasis, it also provides an opportunity to identify potential therapeutical targets and treatment agents for ALD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10556373
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10330455
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10094055
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8529067
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
-
批准号:8360780
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8296548
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8465227
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8662762
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8205418
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
-
批准号:8167659
-
项目类别:
-
资助金额:$5.64万
-
财政年份:2010
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Alcohol Pharmacogenetics in Mexican Americans
-
批准号:7854437
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2009
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7959503
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2009
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7720180
-
项目类别:
-
资助金额:$5.68万
-
财政年份:2008
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7610768
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2007
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Alcohol Pharmacogenetics in Mexican-Americans
-
批准号:7042097
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2003
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
ALCOHOL PHARMACOGENETICS IN MEXICAN AMERICANS
-
批准号:6553724
-
项目类别:
-
资助金额:$4.58万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6593676
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6784107
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6929340
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6663814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
海外基金